PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | entospletinib | C23H21N7O

entospletinib

  • Molecular FormulaC23H21N7O
  • Average mass411.459 Da
  • Monoisotopic mass411.180756 Da
  • ChemSpider ID31042596

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1229208-44-9 [RN]
6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-amin [German] [ACD/IUPAC Name]
6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-amine [ACD/IUPAC Name]
6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phényl]imidazo[1,2-a]pyrazin-8-amine [French] [ACD/IUPAC Name]
6I3O3W6O3B
9874
entospletinib [INN] [USAN]
entospletinib [Spanish] [INN]
entosplétinib [French] [INN]
entospletinibum [Latin] [INN]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

GS-9973 [DBID]
gs9973 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      GS-9973 is a highly selective and orally efficacious Syk inhibitor(IC50= 7.7 nM) which is currently undergoing clinical evaluation for autoimmune and oncology indications. MedChem Express
      GS-9973 is a highly selective and orally efficacious Syk inhibitor(IC50= 7.7 nM) which is currently undergoing clinical evaluation for autoimmune and oncology indications.; IC50 value: 7.7 nM [1]; Target: Syk; The most advanced Syk inhibitor, R406, 1 (or its prodrug form fostamatinib, 2), has shown efficacy in multiple therapeutic indications, but its clinical progress has been hampered by dose-limiting adverse effects that have been attributed, at least in part, to the off-target activities of 1. MedChem Express HY-15968
      GS-9973 is a highly selective and orally efficacious Syk inhibitor(IC50= 7.7 nM) which is currently undergoing clinical evaluation for autoimmune and oncology indications.;IC50 value: 7.7 nM [1];Target: Syk;The most advanced Syk inhibitor, R406, 1 (or its prodrug form fostamatinib, 2), has shown efficacy in multiple therapeutic indications, but its clinical progress has been hampered by dose-limiting adverse effects that have been attributed, at least in part, to the off-target activities of 1. It is expected that GS-9973 is a more selective Syk inhibitor would provide a greater therapeutic window. MedChem Express HY-15968
      Protein Tyrosine Kinase/RTK MedChem Express HY-15968
      Protein Tyrosine Kinase/RTK; MedChem Express HY-15968
      Syk MedChem Express HY-15968

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.5±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.772
Molar Refractivity: 117.8±0.5 cm3
#H bond acceptors: 8
#H bond donors: 2
#Freely Rotating Bonds: 4
#Rule of 5 Violations: 0
ACD/LogP: 3.74
ACD/LogD (pH 5.5): 2.56
ACD/BCF (pH 5.5): 45.63
ACD/KOC (pH 5.5): 455.75
ACD/LogD (pH 7.4): 2.81
ACD/BCF (pH 7.4): 80.04
ACD/KOC (pH 7.4): 799.51
Polar Surface Area: 83 Å2
Polarizability: 46.7±0.5 10-24cm3
Surface Tension: 63.7±7.0 dyne/cm
Molar Volume: 283.1±7.0 cm3

Click to predict properties on the Chemicalize site






Advertisement